Commercialisaton of Biosimilars: Multifunctional teamwork for success-Aarkstore
From bench to bedside, biosimilars continue to dominate boardroom discussions around the world. Operating in a biosimilar world means that companies need to find new and innovative ways to differentiate themselves versus the competition; conversations have moved from clinical differentiation to commercial differentiation. This report will enable you to: Get up-to-speed on the current biosimilars landscape including opportunities, investment drivers, regulatory and policy developments, and the key factors influencing the market. Define team roles and responsibilities across spectrum biosimilar assets lifecycle, including technical and manufacturing, clinical and regulatory, medical affairs, commercial and legal. Set out timings and key stages for commercial strategy development and implementation including guidance on when to involve specific functions. Formulate a plan of attack for data, key performance indicators and pre- versus post-approval activitie...